LoginSignup
Linseneintopf
@Linseneintopf
3Lun·

Cybin

1
4 Comentarios
jkb92@jkb92
3Lun
Take a look at $ATAI or $MNMD, where they are probably already a bit further along.
•
1
•
Ver todas las 2 respuestas adicionales
Imagen de perfil
Erich K.@Erich_aus_der_Steiermark
1Lun
I am currently expanding my position in a targeted manner, as February 2026 is probably the most important month in the company's history. Here are the facts for the watchlist:

Rebranding & Nasdaq move: The change has been complete since January - Cybin is now called Helus Pharma (ticker: HELP). The move to the Nasdaq provides the necessary visibility with the major institutional investors.

CYB003 (Depression): All eyes are waiting for the final updates on the 12-month data. If the remission rates remain stable (most recently an impressive 71%), this is the "golden ticket" for Phase 3.

CYB004 (anxiety disorder): The important topline data from phase 2 are also expected in Q1. A second potential blockbuster in the pipeline.
•
1
•
Únase a la conversación
InscríbaseInicio de sesión